XEMBIFY 200 mg/mL

XEMBIFY 200 mg/mL is a subcutaneous immune globulin solution used to treat immune deficiencies. This product supports the immune system and is administered via subcutaneous injection.

XEMBIFY 200 mg/mL is primarily used to manage primary immune deficiencies. This immune globulin subcutaneous solution helps to replace antibodies that the body lacks, aiding in the prevention of infections. It is often prescribed for individuals who cannot produce sufficient antibodies on their own. The solution is designed for subcutaneous administration, making it a convenient option for those requiring regular immune support.

Common effects of using XEMBIFY 200 mg/mL may include localized reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience mild systemic effects like headache, fatigue, or muscle aches. These effects are generally temporary and should subside as the body adjusts to the treatment.

XEMBIFY 200 mg/mL should be handled with care, ensuring proper storage and administration techniques. It is important to follow the healthcare provider's instructions for subcutaneous injection to minimize the risk of complications. Individuals with a history of severe allergic reactions to immune globulin products should consult their healthcare provider before use.

XEMBIFY 200 mg/mL may interact with certain medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol and other substances that may affect the immune system should be discussed with a healthcare professional.